Differences In Therapeutic Efficacy Between Pressurized Metered-dose Inhaler And Dry Powder Inhaler For Asthma Patients With Small Airway Dysfunction - 03/02/23
Doi : 10.1016/j.jaci.2022.12.787
Susumu Fukahori, MD, PhD 1, Seong Cho, MD FAAAAI 2, Yasushi Obase, MD, PhD 3, Chizu Fukushima, MD, PhD 4, Hiroshi Mukae, MD, PhD 3, Richard Lockey, MD, MD FAAAAI 5
1 University of South Florida, Morsani College of Medicine
2 University of South Florida Morsani Coll
3 Nagasaki University Graduate School of Biomedical Sciences
4 Nagasaki University Hospital
5 University of South Florida
L60
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2022
Pubblicato da Elsevier Masson SAS.
Vol 151 - N° 2S
P. AB337 - febbraio 2023 Ritorno al numero
Articolo precedente
- Step 1-3 Asthma Treatment Among Allergists Affected By Reduced Insurance Coverage
- Desiree Larenas Linnemann, Jonathan Romeo, Barbara Ariue, John Oppenheimer
- MICRODELETION CHROMOSOME SYNDROME - 3,7 MB INTERSTITIAL DELETION OF CHROMOSOME 15Q24.1Q24.3 ASSOCIATED TO IMMUNODEFICIENCY
- Laiane Bezerra Fernandes Capistrano, Daniela Albarello, Allexia Lacerda Soares, Carolina TELO GEHLEN, Arnaldo Porto Neto
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?